Clinical trial
A Prospective, Epidemiological, Cohort Study to Assess the Feasibility of Screening Healthy Asymptomatic Workers for the Presence of SARS-CoV-2 by Pharyngeal Swaps and Serology at Baseline, Day 21 and Day 40
NCT04405466 is registered in ClinicalTrials.gov with Miltenyi Biomedicine GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Epidemiological, Cohort Study to Assess the Feasibility of Screening Healthy Asymptomatic Workers for the Presence of SARS-CoV-2 by Pharyngeal Swaps and Serology at Baseline, Day 21 and Day 40
- Lead sponsor
- Miltenyi Biomedicine GmbH
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 22, 2020
- Completion date
- December 17, 2020
- Enrollment
- 417 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.